SELLAS Life Sciences (SLS) Assets Average (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Assets Average for 8 consecutive years, with $20.8 million as the latest value for Q3 2024.
- On a quarterly basis, Assets Average changed N/A to $20.8 million in Q3 2024 year-over-year; TTM through Sep 2024 was $20.8 million, a N/A change, with the full-year FY2023 number at $13.6 million, down 42.48% from a year prior.
- Assets Average was $20.8 million for Q3 2024 at SELLAS Life Sciences, down from $23.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $43.3 million in Q1 2021 to a low of $20.8 million in Q3 2024.
- A 4-year average of $32.3 million and a median of $32.2 million in 2020 define the central range for Assets Average.
- Peak YoY movement for Assets Average: soared 69.47% in 2020, then tumbled 44.92% in 2022.
- SELLAS Life Sciences' Assets Average stood at $32.3 million in 2020, then decreased by 0.51% to $32.1 million in 2021, then fell by 26.91% to $23.5 million in 2022, then fell by 11.33% to $20.8 million in 2024.
- Per Business Quant, the three most recent readings for SLS's Assets Average are $20.8 million (Q3 2024), $23.5 million (Q4 2022), and $23.9 million (Q1 2022).